Compare CBSH & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBSH | RGEN |
|---|---|---|
| Founded | 1865 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 6.6B |
| IPO Year | 2008 | 1995 |
| Metric | CBSH | RGEN |
|---|---|---|
| Price | $59.02 | $139.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 12 |
| Target Price | $58.28 | ★ $167.67 |
| AVG Volume (30 Days) | ★ 1.3M | 1.1M |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.15% | N/A |
| EPS Growth | 4.39 | ★ 286.96 |
| EPS | ★ 0.96 | 0.15 |
| Revenue | N/A | ★ $141,236,000.00 |
| Revenue This Year | $17.43 | $14.30 |
| Revenue Next Year | $3.43 | $14.52 |
| P/E Ratio | ★ $61.20 | $943.33 |
| Revenue Growth | N/A | ★ 35.10 |
| 52 Week Low | $46.99 | $100.99 |
| 52 Week High | $66.31 | $175.77 |
| Indicator | CBSH | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 72.30 | 58.18 |
| Support Level | $51.60 | $123.05 |
| Resistance Level | $60.21 | $141.46 |
| Average True Range (ATR) | 0.93 | 6.51 |
| MACD | 0.19 | 0.14 |
| Stochastic Oscillator | 93.74 | 59.96 |
Commerce Bancshares Inc operates as the bank holding company for Commerce Bank. The bank is engaged in the general banking business, providing a broad range of retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals, businesses, and municipalities. The company has three reportable segments. The Commercial segment provides lending, leasing, deposit, payment, and cash management services to business and government customers. The Retail Banking segment offers consumer deposits, consumer lending, mortgage banking, and debit and credit card services through its branch network. The Wealth segment provides trust, estate planning, brokerage, and investment management services to individual and institutional clients.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.